Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D. Anthoine, X. Feintrenie.
El cáncer bronquial microcelular.
Press Méd (ed. esp.), 4 (1985), pp. 230-235
[2.]
J. Craig.
Segundo carcinoma pulmonar broncógeno después de un carcinoma de células pequeñas.
Am J Med (ed. esp.), 76 (1984), pp. 1.013-1.020
[3.]
M.D. Abeloff, J. Eggleston, G. Mendelsohn.
Cambios en las características morfológicas y bioquímicas del carcinoma de células pequeñas de pulmón.
Am J Med (ed. esp.), 66 (1979), pp. 351-364
[4.]
R. Yesner.
A unified concept of lung cancer histopathology.
Am Soc Clin Onc Proc, 1 (1977), pp. 271-275
[5.]
D.N. Carney, A.F. Gazdar, M. Nau, J.D. Minna.
Biológica! heterogeneity of small cell lung cancer.
Semin Oncol, 12 (1985), pp. 289-303
[6.]
D.C. Ihde.
Current status of therapy for small cell carcinoma of the lung.
Cancer, 54 (1984), pp. 2.722-2.728
[7.]
M.J. Straus.
Lung cancer..
GruneStratton, (1983), pp. 21-35
[8.]
T.W. Shields.
Surgical resection in the management of small cell carcinoma of the lung.
J Thorac Cardiovasc Surg, 83 (1982), pp. 12-19
[9.]
Editorial.
Small-cell carcinoma of the broncus.
Lancet, 1 (1980), pp. 77
[10.]
M. Irisson, C. Boutin.
Revue de l’état actuel du traitment des cancer anaplasiques bronchiques à petites cellules.
Poumon Coeur, 36 (1980), pp. 197-204
[11.]
H.H. Hansen, M. Rorth.
Lung cancer. En: Cancer chemotherapy.
Ed. Pinedo, Chabner-Elsevier, (1985),
[12.]
H.H. Hansen.
Chemotherapy of advanced small cell anaplastic carcinoma: supperiority of a four-drug combination to a three-drug combination.
Ann Int Med, 89 (1978), pp. 177-181
[13.]
R.K. Oldham, F.A. Greco.
El cáncer pulmonar microcelular, enfermedad curable.
Cancer chemother. Pharmacol, 4 (1980), pp. 173-177
[14.]
R.T. Eagan, L.H. Maurier, R.J. Forcier, M. Tulloh.
Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment and survival.
Cancer, 33 (1974), pp. 527-541
[15.]
J. Aisner, M. Whitacre, D.A. Vanecho, P.H. Wienik.
Combination chemotherapy for small cell carcinoma of the lung.
Cancer Treat Rep, 66 (1982), pp. 221-230
[16.]
J. Klastersky.
Combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide in small cell lung carcinoma.
Proc ASCO, 4 (1985), pp. 78
[17.]
J. Aisner.
Platinum, doxorrubicin, cyclophosphamide and etoposide, PACE, for small cell lung cancer.
Proc ASCO, 4 (1985), pp. 181
[18.]
J. Klastersky.
Combination chemotherapy with adriamycin, etoposide and cyclophosphamide for small cell carcinoma of the lung.
Cancer, 56 (1985), pp. 71-75
[19.]
B.E. Johnson, D.C. Ihde, P.A. Bunn.
Patients with small cell lung cancer treated with combination chemotherapy with or without irradiation.
Ann Int Med, 103 (1985), pp. 430-438
[20.]
R.B. Weiss.
Small cell carcinoma of the lung: therapeutic management.
Ann Int Med, 88 (1978), pp. 522-531
[21.]
R.W. Byhard, J.D. Cox.
Is chest radiotherapy necessary in any of all patients with small cell carcinoma of the lung?.
Yes. Cancer Treat Rep, 67 (1983), pp. 209-215
[22.]
M.H. Cohen.
Is thoracic radition therapy necessary for patients with limited-stage small cell lung cancer?.
No. Cancer Treat Rep, 67 (1983), pp. 217-221
[23.]
H.H. Hansen, P. Dombernowsky, H.S. Hansen.
Chemotherapy versus chemotherapy plus radiotherapy in regional small cell carcinoma of the lung: a randomized trial.
Proc Am Assoc Cancer Res, 20 (1979), pp. 277
[24.]
E. Stevens, L. Einhorn, R. Rohn.
Treatment of limited small cell lung cancer.
Proc Am Soc Clin Oncol, 20 (1979), pp. 435
[25.]
P. Bunn, M. Cohen.
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy in limited stage small cell lung cancer.
Proc Am Soc Clin Oncol, 2 (1983), pp. 200
[26.]
C.A. Pérez, L. Einhorn, R.K. Oldham.
Preliminary report of a randomized trial of radiotherapy to the torax in limited small cell carcinoma of the lung treated with multiagent chemotherapy.
Proc Am Soc Clin Oncol, 2 (1983), pp. 190
[27.]
R.L. Souhami, D.M. Geddes, S.G. Spiro.
Radiotherapy in small cell cancer of the lung treated with combination chemotherapy.
Br Med J, 288 (1984), pp. 1.643-1.644
[28.]
C.A. Pérez.
Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation.
J Clin Oncol, 2 (1984), pp. 1.200-1.206
[29.]
C.F. Lucas.
Morbidity of cranial relapse in small cell lung cancer and the impact of radiation therapy.
Cancer Treat Rep, 70 (1986), pp. 565-570
[30.]
J.T.W. Licciardelli.
Disturbing central nervous system complications following combination chemotherapy and prophylactic whole-brain irradiation in patients with small cell lung cáncer.
Cancer Treat Rep, 69 (1985), pp. 1.429-1.434
[31.]
B.E. Johnson, D.C. Ihde.
Neurologic, neuropsychologic and computed cranial tomography scan abnormalities in 2 to 10 years survivors of small-cell lung cancer.
J Clin Oncol, 3 (1985), pp. 1.669-1.676
[32.]
S.G. Spiro.
La quimioterapia en el cáncer pulmonar de células pequeñas.
Br Med J (ed. esp.), 1 (1986), pp. 17-20
[33.]
R. Feld, G.H. Clamon.
Short course prophylactic cranial irradiation for small cell lung cancer.
Am J Clin Oncol, 8 (1985), pp. 371-376
[34.]
N. Thatcher.
Three month's treatment with chemotherapy and radiotherapy for small cell lung cancer.
Br J Cancer, 52 (1985), pp. 327-332
[35.]
N. Thatcher, R.D. James.
Three month's treatment with cyclophosphamide VP16213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer.
Cancer, 56 (1985), pp. 1.332-1.336
[36.]
R. Feld, W.K. Evans.
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
J Clin Oncol, 2 (1984), pp. 294-298
[37.]
F.A. Greco, D.H. Johnson.
Chemotherapy of small cell lung cancer.
Sem Oncol, 4 (1985), pp. 31-37
[38.]
M.H. Cohen, P.J. Creaven, B.E. Fossieck.
Intensive chemo-therapy of small cell bronchogenic carcinoma.
Cancer Treat Rep, 61 (1977), pp. 349-354
[39.]
D.H. Johnson, F.A. Greco.
Extensivo stage small bronchogenic carcinoma intensive induction chemotherapy with highdose cyclophosphamide plus high dose etoposide.
J Clin Oncol, 3 (1985), pp. 170-178
[40.]
M. Markman, M.D. Abelof.
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Cancer Treat Rep, 69 (1985), pp. 161-166
[41.]
S. Lowenbraun.
Combination chemotherapy in small cell lung carcinoma.
Cancer, 54 (1984), pp. 2.344-2.400
[42.]
J. Klastersky.
Active combinations of SCLC. Discussion of the importance of dosage and scheduling.
Lung Cancer Working Party, (1984),
[43.]
M. Valdivieso, F. Cabanillas.
Effects of intensive induction chemotherapy for extensive disease small cell bronchogenic carcinoma.
Am J Med, 76 (1984), pp. 405-410
[44.]
M.R. O’Donnell.
Intensive induction chemotherapy for small cell anaplastia carcinoma of the lung.
Cancer Treat Rep, 69 (1985), pp. 571-575
[45.]
J.P. Sculier, J. Klastersky, P. Stryckmans.
Late intensification in small cell lung cancer a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation.
J Clin Oncol, 3 (1985), pp. 184-191
[46.]
G. Spitzer.
High-dose intensification therapy with autologous bone marrow support for limited small cell bronchogenic carcinoma.
J Clin Oncol, 4 (1986), pp. 4-10
[47.]
S. Harland, D. Pérez, J. Millar, I. Smith.
A randomized trial of cyclophosphamide pretreatment («priming») before short-duration chemotherapy for small cell lung carcinoma.
Eur J Cancer Clin Oncol, 21 (1985), pp. 61-66
[48.]
S.N. Wolff, F.A. Greco.
Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung.
Cancer Treat Rep, 70 (1986), pp. 583-587
[49.]
G. Dangaard, H.H. Hansen, M. Rorth.
Phase II study of vindesine, cisplatin and hexamethylmelamine in small cell carcinoma of the lung.
Cancer Treat Rep, 68 (1984), pp. 1.179-1.185
[50.]
N. Niederle, J. Schutte.
Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
Cancer Treat Rep, 68 (1984), pp. 791-795
[51.]
D.F. Chiuten, M. Valdivieso.
Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
Cancer Treat Rep, 70 (1986),
[52.]
W.K. Evans, D. Osoba, R. Feld.
VP-16 alone and in combination with cisplatin for relapse in small cell lung cancer.
Cancer, 53 (1984), pp. 1.461-1.466
[53.]
W.K. Evans, D. Osoba, R. Feld.
Etoposide and cisplatin. An effective treatment for relapse in small cell lung cancer.
J Clin Oncol, 3 (1985), pp. 65-71
[54.]
L.L. Porter, F.A. Greco.
Cisplatin and etoposide combination chemotherapy for refractary small cell carcinoma of the lung.
Cancer Treat Rep, 69 (1985), pp. 479-484
[55.]
A. Ordónez, J. Vicente, G. Martín.
Tratamiento quimioterápico del carcinoma broncopulmonar microcelular.
Comunicación al I Congreso Conjunto de las Sociedades Oncológicas Españolas, (1986),
[56.]
J.H. Goldie, A.J. Coldman.
Genetic instability in the development of drug resistance.
Sem in Oncology, 3 (1985), pp. 222-230
[57.]
J.H. Godie, A.J. Coldman.
The genetic origin of drug resistance in neoplasms: implications for systemic therapy.
Cancer Res, 44 (1984), pp. 3.643-3.653
[58.]
J.H. Goldie, A.J. Coldman.
A mathematical model for relatin drug sensivity of tumours to their spontaneous mutation rate.
Cancer Treat Rep, 63 (1979), pp. 1.727-1.733
[59.]
L.E. Schnipper.
Clinical implications of tumor cell heterogeneity.
N Eng J Med, 314 (1986), pp. 1.423-1.431
[60.]
J.H. Goldie, A.J. Coldman.
Rationale for the use of alternating non-cross-resistant chemotherapy.
Cancer Treat Rep, 66 (1982), pp. 439-449
[61.]
C. Gropp.
Treatment of small cell lung cancer by different chemotherapy regimens.
Cancer Treat Rev, 10 (1983), pp. 111-120
[62.]
N. Murray.
Cyclic alternating chemotherapy for small cell carcinoma of the lung.
Cancer Treat Rep, 69 (1985), pp. 1.241-1.242
[63.]
W.K. Evans.
Canadian multicentre randomized trial comparing sequential and alternating administration of two non-cross limited small cell carcinoma of the lung.
Proc ASCO, 4 (1985), pp. 177
[64.]
D. Ettinger.
Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine and VP-16 in small cell carcinoma of the lung.
Cancer, 49 (1982), pp. 1.544-1.554
[65.]
G.E. Goddman, J. Blasko.
Concurrent chemotherapy with VP-16-vincristine-adriamycin-cyclophosphamide (EVAC) versus alternating chemotherapy with VP-16-cisplatine and vincristine-adriamycin-cyclophosphamide (VPP/VAC) in limited small cell cancer.
Proc ASCO, 5 (1986), pp. 169
[66.]
D. Ettinger.
A randomized comparison of conventional chemotherapy with inmediate alternation of non-cross-resistant chemotherapy in extensivo disease small cell lung cancer.
Proc ASCO, 5 (1986), pp. 169
[67.]
R.S. Aroney, D.R. Bell.
Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung.
Cancer, 49 (1982), pp. 2.449-2.456
[68.]
J.R. Daniels, L.Y. Chalk.
Chemotherapy of small cell carcinoma of the lung. A randomized comparison of alternating and sequential combination chemotherapy programs.
J Clin Oncol, 2 (1984), pp. 1.192-1.198
[69.]
K. Osterlind, P. Kragh.
Prognostic factors in small cell lung cancer.
Cancer Res, 46 (1986), pp. 4.189-4.194
[70.]
K. Osterlind.
Continous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.
Cancer Res, 43 (1983), pp. 6.085-6.089
[71.]
M.H. Cohen, D.C. Ihde.
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Cancer Treat Rep, 63 (1979), pp. 163-170
[72.]
S. Krauss, S. Lowenbraum, A. Bartolucci.
Alternating non-cross-resistant drug combinations in the treatment of metastatic small cell carcinoma of the lung.
Cancer Clin Trials, 4 (1981), pp. 147-156
[73.]
B.I. Sikic.
Alternating non-cross resistant chemotherapy of small cell lung cancer..
Current status and new developments. Orlando, Fla, Academia Press, (1984), pp. 191-198
[74.]
J.A. Elliot, K. Osteling, H.H. Hansen.
Cyclic alternating «non-cross-resistant» chemotherapy in the management of small cell anaplastic carcinoma of the lung.
Cancer Treat Rev, 11 (1984), pp. 1-4
[75.]
J.F. Smyth, H.H. Hansen.
Current status of research into small cell carcinoma of the lung.
Eur J Cancer Clin Oncol, 21 (1985), pp. 1.295-1.298
[76.]
H.H. Hansen.
Principles for the comprehensive management of small cell lung cancer. Lung cancer: current trends and future prospects.
Lung Cancer Working Party, (1984),
[77.]
C. Boni.
Cisplatinum plus VP16 chemotherapy as a frontline treatment in small cell lung cancer.
Proc ASCO, 4 (1985), pp. 196
[78.]
D. Bergsagel, R. Feld.
Small cell lung cancer is still a problem.
J Clin Oncol, 2 (1984), pp. 1.189-1.195
[79.]
R.B. Natale, B. Shank, B.S. Hilaris, R.E. Wittes.
Combination cyclophosphamide, adrimycin and vincristine repidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer.
Am J Med, 79 (1985), pp. 303-308
[80.]
G.H. Clamon, R. Feld, W.A.K. Evans.
Effect of adjuvant central iv. hyperalimentation on the normal and response to treatment of patients with small cell lung cancer.
Cancer Treat Rep, 69 (1984), pp. 167-171
Copyright © 1988. Sociedad Española de Neumología y Cirugía Torácica
